Hurel Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)
  • Investors
  • 6

Hurel General Information

Description

Developer of advanced micro-liver tissue designed to focus on microfluidic cell-based assay platforms. The company's micro-liver tissue offers metabolic competency and endurance of cell culture that helps to simulate pharmacokinetic interactions among multiple tissues and organs, enabling physicians to endure for much longer time periods than traditional hepatic systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • North Brunswick Township, NJ
  • United States
+1 (310) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hurel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 29-Jun-2018 Cancelled Generating Revenue
4. Later Stage VC (Series A3) 24-Sep-2014 00000 0000 000.00 Completed Generating Revenue
3. Corporate 27-Jun-2013 00.00 Completed Generating Revenue
2. Later Stage VC (Series A) 03-Apr-2013 $9.2M $9.2M 000.00 Completed Generating Revenue
1. Seed Round Completed Startup
To view Hurel’s complete valuation and funding history, request access »

Hurel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A4 0,000,000 00.000000 000 00.00 00.00 00 00.00 00.000
Series A3 0,000,000 00.000000 000 00.00 00.00 00 00.00 0.000
Series A2 2,380,440 $0.000100 10% $0.7 $0.7 1x $0.7 7.68%
Series A1 5,860,673 $0.000100 10% $0.71 $0.71 1x $0.71 18.91%
To view Hurel’s complete cap table history, request access »

Hurel Executive Team (7)

Name Title Board Seat Contact Info
Robert Freedman Chief Executive Officer & Chairman
Christian Darabant Chief Operating Officer & Executive Vice President
Cheul Cho Ph.D Chief Scientific Officer
Leslie Benet Ph.D Co-Founder & Chairman of Scientific Advisory Board
Martin Yarmush MD Chief Scientific Adviser
You’re viewing 5 of 7 executive team members. Get the full list »

Hurel Board Members (5)

Name Representing Role Since
Bruce Tatarian Self Board Member 000 0000
James MacDonald Ph.D Self Board Member 000 0000
Leslie Benet Ph.D Hurel Co-Founder & Chairman of Scientific Advisory Board 000 0000
Raymond Wong Spring Mountain Capital Board Member 000 0000
Robert Freedman Hurel Chief Executive Officer & Chairman 000 0000
To view Hurel’s complete board members history, request access »

Hurel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hurel Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnston Associates Venture Capital Minority 000 0000 000000 0
Humane Society Corporation Minority 000 0000 000000 0
Athena Capital Partners (Beverly Hills) Venture Capital Minority 000 0000 000000 0
James Satloff Angel (individual) Minority 000 0000 000000 0
Spring Mountain Capital Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »